sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

Paramyxoviruses as Vaccine Vectors Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

$698,609

Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Diagnosing and predicting risk in children with SARS-CoV-2- related illness

$698,415

Jane C Burns · University Of California, San Diego · R61 · FY2021 · HD

Impact of the COVID-19 pandemic on patient outcomes, telehealth care delivery, and treatment for unhealthy alcohol use in vulnerable patients with advanced liver disease across two healthcare systems

$698,400

Mandana Khalili · University Of California, San Francisco · R01 · FY2024 · AA

Severity Predictors Integrating salivary Transcriptomics and proteomics with Multi neural network Intelligence in SARS-CoV2 infection in Children (SPITS MISC)

$698,020

Usha Sethuraman · Central Michigan University · R61 · FY2022 · HD

Intensifying Community Referrals for Health: The SINCERE Intervention to Address COVID-19 Health Disparities

$697,753

Andrea Schneider Wallace · University Of Utah · R01 · FY2021 · NR

Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma

$697,498

William Gerald Teague · University Of Virginia · R01 · FY2024 · AI

MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION

$697,447

Anne M Manicone · University Of Washington · R01 · FY2025 · HL

Genetic-epigenetic and aging interactions at COVID- 19 host response loci in Down syndrome and mouse models

$696,828

Benjamin Tycko · Hackensack University Medical Center · R01 · FY2020 · HD

Project 2

$696,607

Michael S. Diamond · Washington University · U19 · FY2025 · AI

Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program to Improve the Functioning of Persons Suffering from Post-acute Sequelae of SARS-CoV-2 infection (PASC): A Randomized Controlled

$696,313

Timothy R Dillingham · University Of Pennsylvania · R01 · FY2023 · HD

Psychosocial Factors and Lupus Disease Progression Among African American Women

$696,209

H. David Chae · Tulane University Of Louisiana · R01 · FY2021 · AR

Inhibitors of protein-protein interactions

$696,075

Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions

$695,569

Harel Dahari · Loyola University Chicago · R01 · FY2024 · AI

Leveraging community health workers to improve SARS-CoV-2 testing and mitigation among criminal justice-involved individuals accessing a corrections-focused community-based organization

$695,369

Matthew Akiyama · Albert Einstein College Of Medicine · R01 · FY2023 · MD

Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1

$695,359

Priyamvada Acharya · Duke University · R01 · FY2022 · AI

NYC Transit Workers and COVID-19: Impact of Multilevel Interventions

$695,282

Robyn R.m. Gershon · New York University · R01 · FY2023 · NR

Discovery of SARS-CoV-2 antivirals using a replicon assay

$695,135

Stefan G Sarafianos · Emory University · R01 · FY2025 · AI

Regulation of inflammatory gene expression during SARS2 infection

$695,078

Ivan Marazzi · University Of California-Irvine · R01 · FY2023 · AI

Alaska Native Communities Advancing Vaccine Uptake

$694,994

Julie Beans · Southcentral Foundation · R01 · FY2023 · AI

Influence of the nasal microbiome on host susceptibility and response to respiratory viruses

$694,662

Cindy Liu · George Washington University · R01 · FY2024 · AI

Community Developed Technology-Based Messaging to Increase SARS-CoV-2 Vaccine Uptake Among People Who Inject Drugs

$694,606

Ian David Aronson · New York University · R01 · FY2021 · DA

Immunologic basis of cardiac disease after severe COVID-19

$694,590

Chetan N Shenoy · University Of Minnesota · R01 · FY2022 · HL

Paramyxoviruses as Vaccine Vectors Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Diagnosing and predicting risk in children with SARS-CoV-2- related illness

Impact of the COVID-19 pandemic on patient outcomes, telehealth care delivery, and treatment for unhealthy alcohol use in vulnerable patients with advanced liver disease across two healthcare systems

Severity Predictors Integrating salivary Transcriptomics and proteomics with Multi neural network Intelligence in SARS-CoV2 infection in Children (SPITS MISC)

Intensifying Community Referrals for Health: The SINCERE Intervention to Address COVID-19 Health Disparities

Health and Aging in Africa: Longitudinal Studies of an INDEPTH Community

Clinical analysis and therapeutic development of exosomal ACE2

Clinical analysis and therapeutic development of exosomal ACE2

Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma

MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION

Genetic-epigenetic and aging interactions at COVID- 19 host response loci in Down syndrome and mouse models

Project 2

Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program to Improve the Functioning of Persons Suffering from Post-acute Sequelae of SARS-CoV-2 infection (PASC): A Randomized Controlled

Psychosocial Factors and Lupus Disease Progression Among African American Women

Inhibitors of protein-protein interactions

Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions

Leveraging community health workers to improve SARS-CoV-2 testing and mitigation among criminal justice-involved individuals accessing a corrections-focused community-based organization

Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1

NYC Transit Workers and COVID-19: Impact of Multilevel Interventions

Discovery of SARS-CoV-2 antivirals using a replicon assay

Regulation of inflammatory gene expression during SARS2 infection

Alaska Native Communities Advancing Vaccine Uptake

Influence of the nasal microbiome on host susceptibility and response to respiratory viruses

Community Developed Technology-Based Messaging to Increase SARS-CoV-2 Vaccine Uptake Among People Who Inject Drugs

Immunologic basis of cardiac disease after severe COVID-19